**ROLE SUMMARY**
The disease burden for both Influenza and COVID-19 is high, causing millions of cases, hundreds of thousands of hospitalizations and tens of thousands of deaths in the US each year. The US influenza and COVID-19 vaccine market is a growing, high-value, dynamic market, estimated to reach significant potential with stand-along and combination vaccines. The market is currently undifferentiated and ripe for disruption. Our Combination Vaccine has the potential to transform...